This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Pablo Tebas, MD; Jose A. Arzauga, MD; Feliciano Roman, MD; Ramon P. Maestu, MD; Juan M. L. de Letona, MD
Madrid, Spain

Arch Intern Med. 1992;152(8):1726.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

We have read with interest the excellent articles by Strauss¹ and Cockerell² regarding the endocrine and cutaneous manifestations of acquired immunodeficiency syndrome. In neither of these articles is anything mentioned about porphyria cutanea tarda (PCT), a metabolic illness with prominent cutaneous manifestations associated with infection with human immunodeficiency virus (HIV). We have had the opportunity to treat a patient in whom PCT was diagnosed.

Report of a case.—

A 44-year-old man, who had occasionally used intravenous drugs and drank 100 g of alcohol per day, sought medical attention because of cutaneous lesions on the forehand, photosensitivity, and increased fragility to trauma, which appeared in the last few months. He also had a discrete elevation of transaminase levels. Twenty-four-hour urine coproporphyrin and uroporphyrin levels were elevated (509 ug/24 h and 1029 µg/24 h, respectively). Porphyria cutanea tarda was diagnosed, and periodical phlebotomies were begun, which effected . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?